Von Willebrand disease (VWD) is one of the most common hereditary disorders of primary haemostasis. Females with VWD often report heavy menstrual bleeding (HMB) that can significantly impact health-related... HTML Version |
PDF Version
|
Print the excerpt
Research and Practice in Thrombosis and Haemostasis 2026; 10(3): 103418
Hemophilia carriers (HCs) and women with von Willebrand disease (VWD) receive specialized obstetric care because of a higher chance for postpartum bleeding and potential bleeding in the neonates. It is... HTML Version |
PDF Version
|
Print the excerpt
The efficiency of ligand binding assay (LBA)-based immunogenicity assessment can be compromised by the presence of high concentrations of soluble pharmacological target. This is particularly challenging... HTML Version |
PDF Version
|
Print the excerpt
By requesting access to the "WillebrandXPERT" service, I agree that GNM Healthcare Group Companies USA, Inc. may use the data acquired during my access request to provide me with weekly
information related to its services in accordance with the
Privacy Policy.
You have the right to access, rectify and delete your data, which you can exercise by sending your request to
dpo@gnmhealthcare.com.
You can exercise your right to object by requesting the deletion of your data at any time by clicking on the "Delete my data" link.
